Endotherapy Devices Market Scope
Endotherapy Devices are used to treat the diseases that require endotherapy procedures such as cancers and gastrointestinal diseases. These devices are used to perform endoscopy, which can be either surgical or non-surgical, used for restricting any kind of abnormality inside the body. The major symptoms that can find by these devices are used to examine chronic pancreatitis, ulcers, stomach bleeding, abdominal pain, and others. It is seen that, according to the World Health Organization (WHO), in 2018, about 9.6 million individuals were died due to cancer across the globe, hence the prevalence of chronic diseases coupled with need dor minimal time for surgery is boosting the industry.
The market study is being classified by Type (GI Devices & Accessories (Biopsy Forceps, Injection Needles, Polypectomy Snares, Graspers, Hemoclips, and Others), ERCP Devices & Accessories ([Guide Wire, Sphincterotome, Catheter, Extraction Basket, Extraction Balloon, Balloon Dilation, Plastic Stent, Metal Stents, and Others) and Others), by Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuro-endoscopy, Gastrointestinal Endoscopy and Other) and major geographies with country level break-up.
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Endotherapy Devices market throughout the predicted period.
Olympus (Japan), Stryker (United States), Boston Scientific (United States), Fujifilm (Japan), Conmed (United States), Medtronic (Ireland), Karl Storz (Germany), Johnson & Johnson (United States), Smith & Nephew (United Kingdom) and Hoya (Japan) are some of the key players profiled in the study.
AdvanceMarketAnalytics has segmented the market of Global Endotherapy Devices market by Type, Application and Region.
On the basis of geography, the market of Endotherapy Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
On 5th March 2018, Boston Scientific acquired EMcision, a privately held medical device company that is committed to improving the lives of cancer patients. The main aim of this acquisition is that the company would expand its endotherapy devices product portfolio, and thus boosts revenue generation.
- Rising Trend of Surgeries that takes Minimal Time, With fewer scares
- Increasing Geriatric Population across Globe
- Prevalence Diseases such as Orthopedic Diseases, Gastrointestinal conditions, among Others
- Demand for Rapid Recovery Propels, Which in turn rise in the Demand for Technologically Advanced Endotherapy Devices
- Spending more Investment in Emergency Economics Related to the Medical sector can offer a Profitable Expansion of the Market
- The Dearth of Skilled Endoscopic Technicians can Hamper the Market
- High Price of these Endoscopic Devices
- Risk of Infections Associated with these Devices
- Low Awareness Regarding these Devices in some Untapped Regions
Key Target AudienceEndotherapy Devices Manufactures, Endotherapy Devices Distributors, Potential Investors, Research and Organisations, Healthcare Sectors, End-Users and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase